image

The best stocks to buy since 1993

Latest issue now available

Xaar - FY25 will see jumpoff with 15p eps forecast

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • XAR
  • Price:
  • 175p
Ahead of reporting FY22 on 29 March, Xaar said it expects sales to be up 24% (9% organic) and it is on track to deliver a profit for the year despite continuing to invest in the business, with brokers expecting a £1.9m profit/eps 2.3p. Net cash was £8.6m at the year end. Further operational and strategic progress has been made: in November, Xaar launched its Aqueous printhead and by March it will have completed the factory reorganisation to deliver efficiencies. FY22 also saw Covid-19’s impact in China hitting Printhead sales and this year hinges on how fast China’s operations recover so FY23 may be a bit of a stub year. Next year, forecasts are for £90m sales, £5.1m pretax profit and eps of 5.2p but then 2025 sees real jump off t ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe